Cancer, identified by the ISSN 0008-543X, is a prestigious semi-monthly journal published by the American Cancer Society in the United States that serves as a leading venue for high-impact research in oncology. As a non-open access publication with optional open access options, it maintains a strong reputation within the scientific community, consistently ranking in the top tier of the medical sciences category according to the Chinese Academy of Sciences journal rankings, typically securing a position in Zone 1 or Zone 2. Indexed in the Science Citation Index (SCI), the journal publishes rigorous studies spanning the broad spectrum of cancer research, including etiology, diagnosis, treatment, prevention, and epidemiology, with a particular emphasis on multidisciplinary integration and clinical translation. Due to its stringent peer-review process and high standards for methodological rigor and novelty, Cancer attracts intense competition and maintains a high rejection rate, reflecting its commitment to disseminating only work of significant academic and clinical value. Consequently, it remains an authoritative platform for researchers seeking to publish impactful findings in the field of oncology, provided they are prepared to navigate its demanding editorial requirements and potentially extended publication timelines.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com